About this trial
The aim of the proposed study is to investigate the use of resting-state Electroencephalogram (EEG)-Based Brain Entropy (EBDBE) and auditory brainstem responses (ABR) as an objective measure of tinnitus improvement following the use of a bimodal stimulation device in individuals with tinnitus after six weeks of bi-modal stimulation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years and over at time of consent
Ability to read and understand English
Willing and able to provide and understand informed consent
Willing to commit to the full duration of the investigation
Disqualifiers
Subjective tinnitus, where pulsatility is the dominant feature (only for participants in treatment group)
Objective tinnitus
Can't hear acoustic stimulation of the Lenire device within its mid- range volume setting
Began wearing hearing aids within the past 3 months
Trial design
Parallel
Treatments tested in this trial
Lenire Device
DeviceThe Lenire device is a non-invasive stimulation system designed to reduce the symptoms of chronic subjective tinnitus. It includes a controller that is connected to headphones for sound delivery to the ears and a mouthpiece that provides mild electrical stimulation to the surface of the tongue. Users are recommended to use the device for 60 minutes daily, either in two consecutive 30-minute sessions or at different times throughout the day, for a minimum of 36 hours.
Treatment groups
Trial outcomes
Primary outcomes
Change in brain waves at 6 weeks
Assessed via 32-channel EEG recording
Secondary outcomes
Correlation between change in EBDBE, ABR, THI, and PSS-10
Assessed via Tinnitus Handicap Inventory (THI) and Perceived Stress Scale (PSS), for which lower scores indicate a better outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.